Skip to main content
C

CAMBIUM BIO LIMITED — Investor Relations & Filings

Ticker · CMB ISIN · AU0000327769 ASX Professional, scientific and technical activities
Filings indexed 503 across all filing types
Latest filing 2024-04-04 Regulatory Filings
Country AU Australia
Listing ASX CMB

About CAMBIUM BIO LIMITED

https://www.cambium.bio

Cambium Bio Limited is a clinical-stage regenerative medicine company focused on developing innovative cellular therapies to treat unmet medical needs in ophthalmology and inflammatory diseases. The company's primary focus is on its lead candidate, EluRegen, a first-in-class topical biologic designed for the treatment of corneal epithelial defects and dry eye disease. Utilizing its proprietary technology platforms, the company aims to harness the regenerative potential of biologics to provide effective treatments for chronic conditions. In addition to its ophthalmic pipeline, the company maintains assets in the field of mesenchymal stem cell therapies, including Progenza, which targets osteoarthritis and neuropathic pain. The company emphasizes a data-driven approach to clinical development, seeking to improve patient outcomes through advanced tissue engineering and cell-based solutions.

Recent filings

Filing Released Lang Actions
Final Director's Interest Notice - Leo Lee 2 pages 264.2KB
Regulatory Filings
2024-04-04 English
Cambium Bio Raises A$3.48 Million in Strategic Placement 3 pages 188.3KB
Regulatory Filings
2024-04-04 English
Results of Meeting 2 pages 175.1KB
Regulatory Filings
2024-03-27 English
Regeneus secures shareholder approval for merger 1
Regulatory Filings
2024-03-27 English
Optimisation of Progenza Patent Portfolio 2 pages 137.3KB
Regulatory Filings
2024-03-19 English
Half Yearly Report and Accounts 21 pages 1.5MB
Regulatory Filings
2024-02-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.